Cite
HARVARD Citation
Hansen, A. et al. (2015). Choice of Starting Dose for Biopharmaceuticals in First‐in‐Human Phase I Cancer Clinical Trials. Oncologist. pp. 653-659. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hansen, A. et al. (2015). Choice of Starting Dose for Biopharmaceuticals in First‐in‐Human Phase I Cancer Clinical Trials. Oncologist. pp. 653-659. [Online].